Levilex Oral Solution contains Levetiracetam 500mg/5ml as its active ingredient and is indicated for the treatment of epilepsy. It is an antiepileptic drug used as adjunctive therapy in the management of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in both adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and reducing seizure frequency. The oral solution formulation allows for flexible dosing, particularly beneficial for patients with swallowing difficulties or requiring dose adjustments. Levilex is rapidly absorbed with a bioavailability of nearly 100%, and it is minimally metabolized by the liver, with renal excretion being the primary elimination route. Common adverse effects may include somnolence, dizziness, fatigue, and irritability. Dose adjustments are recommended in patients with renal impairment. Levilex Oral Solution should be administered as prescribed by a healthcare professional, with careful monitoring for efficacy and tolerability. It is important to avoid abrupt discontinuation to prevent seizure exacerbation. This medication should be stored at controlled room temperature and kept out of reach of children.